Concierge Program

Value of Strategic Partnership

Simulations Plus concierge services provide one-on-one support for our clients and partners as they navigate the long and winding road of model-informed drug discovery. We help CROs, CDMOs, biotech, startups, regulatory authorities, and mid-to large-size pharmaceutical companies navigate the ever-evolving modeling and simulation landscape by bringing our scientific expertise in PBPK/PBBM modeling, QST/QSP, pharmacometrics, regulatory interaction and much more.

This exclusive program provides:

Access to Scientists

Access to scientists with experience developing drugs across a multitude of indications in pharma, biotech, regulatory, and CROs.

Simulations Plus Team

Discounts

Discounted rates for professional development in hands-on training across all the GastroPlus® and Monolix™ software platforms.

Workshops

Priority

Prioritization of funded collaborations for software enhancements.

Collaborations

Co-publication

Collaboration on scientific publications highlighting consulting work & research tools.

Resource Center

Updates

Updates on Simulations Plus development roadmaps, personalized license agreements, and longer trial periods for unlicensed modules.

Customer Portal

Connection

Networking and collaboration opportunities with our GastroPlus user community and User Groups.

GastroPlus User Group

Good News! For Simulations Plus clients, our experts provide:

• Machine Learning to assist with drug efforts

Population PK/PD analyses

• A bridge between Physiologically Based Pharmacokinetic and Biopharmaceutics Modeling (PBPK & PBBM)

Noncompartmental Analysis in a validated environment with submission-ready report

• Expanded Pharmocodynamic Modeling

• Application of existing validated QSP & QST models in Drug-Induced Liver Injury (DILI), Acute kidney Injury (AKI), Nonalcoholic Steatohepatitis, Nonalcoholic Fatty Liver Disease (NAFLD), Idiopathic Pulmonary Fibrosis (IPF), and heart failure to support regulatory interactions and internal decision making

• Model analysis using a variety of analytical techniques and multiple tools, including Monolix™, PKanalix™, Simulx™, GastroPlus® and more

• Assistance with data assembly, analysis. and reporting for internal decision makings and Global Regulatory Interaction

• Custom quantitative systems pharmacology and toxicology (QSP/QST) models to support pre-clinical/clinical drug development

From the point at which you begin sketching chemical structures, all the way through filings and post-approval, Simulations Plus can help!